The University of Cincinnati Cancer Center is the first site in the Midwest to launch a phase 2 clinical trial to test a pancreatic cancer vaccine.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Pancreatic cancer vaccine trial to begin at Cincinnati hospital
